Chenhui Li

Chenhui Li

Auto-generated profile, based on publicly available information

Chenhui Li

Guangzhou Medical University, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Soil Biology and Biochemistry
Verified
Journal Article
Closed access
CLChenhui Li
Chenhui Li
LFLisa M. Fultz
Lisa M. Fultz
JMJennifer Moore-Kucera
Jennifer Moore-Kucera
VAVeronica Acosta-Martínez
Veronica Acosta-Martínez
MKMamatha Kakarla
Mamatha Kakarla
DWDavid C. Weindorf
David C. Weindorf

25 June 2020 in Soil Science Society of America Journal
Verified
Journal Article
Closed access
PDF file
CLChenhui Li
Chenhui Li
ACAmanda Cano
Amanda Cano
VAVeronica Acosta-Martinez
Veronica Acosta-Martinez
KVKristen Veum
Kristen Veum
JMJennifer Moore‐Kucera
Jennifer Moore‐Kucera

20 December 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
ZYZhang Yu-zhuo
Zhang Yu-zhuo
JLJiangpeng Lin
Jiangpeng Lin
ZYZhixuan You
Zhixuan You
Hengjia TuHengjia Tu
Hengjia Tu
PHPeng He
Peng He
GQGuibin Qiao
Guibin Qiao
Background: Exploring the cancer risks of rheumatoid arthritis (RA) patients with disease-modifying anti-rheumatic drugs (DMARDs) can help detect, evaluate, and treat malignancies at an early stage for these patients. Thus, a comprehensive analysis was conducted to determine the cancer risk of RA patients using different types of DMARDs and analyze their relationship with tumor mutational burdens (TMBs) reflecting immunogenicity.Methods: A thorough search of PubMed, EMBASE, Web of Science, and Medline was conducted up to 20 August 2022. Standardized incidence ratios (SIRs) were constructed with a random-effect model to determine risks for different types of malignancies in comparison with the general population. We also analyzed the correlation between SIRs and TMBs using linear regression (LR).Results: From a total of 22 studies, data on 371,311 RA patients receiving different types of DMARDs, 36 kinds of malignancies, and four regions were available. Overall cancer risks were 1.15 (SIR 1.15; 1.09–1.22; p < 0.001) and 0.91 (SIR 0.91; 0.72–1.14; p = 0.402) in RA populations using conventional synthetic DMARDs (csDMARDs) and biologic DMARDs (bDMARDs), respectively. RA patients taking csDMARDs displayed a 1.77-fold lung cancer risk (SIR 1.77; 1.50–2.09; p < 0.001), a 2.15-fold lymphoma risk (SIR 2.15; 1.78–2.59; p < 0.001), and a 1.72-fold melanoma risk (SIR 1.72; 1.26–2.36; p = 0.001). Correlation coefficients between TMBs and SIRs were 0.22 and 0.29 from those taking csDMARDs and bDMARDs, respectively.Conclusion: We demonstrated a cancer risk spectrum of RA populations using DMARDs. Additionally, TMBs were not associated with elevated cancer risks in RA patients following immunosuppressive therapy, which confirmed that iatrogenic immunosuppression might not increase cancer risks in patients with RA.Interpretation: Changes were similar in cancer risk after different immunosuppressive treatments, and there was a lack of correlation between SIRs and TMBs. These suggest that we should look for causes of increased risks from the RA disease itself, rather than using different types of DMARDs.

5 July 2022 in Water Research
Verified
Journal Article
Open access
MBMohamed Bayati
Mohamed Bayati
HHHsin-Yeh Hsieh
Hsin-Yeh Hsieh
SHShu-Yu Hsu
Shu-Yu Hsu
CLChenhui Li
Chenhui Li
ERElizabeth Rogers
Elizabeth Rogers
CLChung-Ho Lin
Chung-Ho Lin
Recent SARS-CoV-2 wastewater-based epidemiology (WBE) surveillance have documented a positive correlation between the number of COVID-19 patients in a sewershed and the level of viral genetic material in the wastewater. Efforts have been made to use the wastewater SARS-CoV-2 viral load to predict the infected population within each sewershed using a multivariable regression approach. However, reported clear and sustained variability in SARS-CoV-2 viral load among treatment facilities receiving industrial wastewater have made clinical prediction challenging. Several classes of molecules released by regional industries and manufacturing facilities, particularly the food processing industry, can significantly suppress the SARS-CoV-2 signals in wastewater by breaking down the lipid-bilayer of the membranes. Therefore, a systematic ranking process in conjugation with metabolomic analysis was developed to identify the wastewater treatment facilities exhibiting SARS-CoV-2 suppression and identify and quantify the chemicals suppressing the SARS-COV-2 signals. By ranking the viral load per diagnosed case among the sewersheds, we successfully identified the wastewater treatment facilities in Missouri, USA that exhibit SARS-CoV-2 suppression (significantly lower than 5 × 1011 gene copies/reported case) and determined their suppression rates. Through both untargeted global chemical profiling and targeted analysis of wastewater samples, 40 compounds were identified as candidates of SARS-CoV-2 signal suppressors. Among these compounds, 14 had higher concentrations in wastewater treatment facilities that exhibited SARS-CoV-2 signal suppression compared to the unsuppressed control facilities. Stepwise regression analyses indicated that 4-nonylphenol, palmitelaidic acid, sodium oleate, and polyethylene glycol dioleate are positively correlated with SARS-CoV-2 signal suppression rates. Suppression activities were further confirmed by incubation studies, and the suppression kinetics for each bioactive compound were determined. According to the results of these experiments, bioactive molecules in wastewater can significantly reduce the stability of SARS-CoV-2 genetic marker signals. Based on the concentrations of these chemical suppressors, a correction factor could be developed to achieve more reliable and unbiased surveillance results for wastewater treatment facilities that receive wastewater from similar industries.

11 June 2022 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
YYYang Yuan
Yang Yuan
YLYouzhen Liu
Youzhen Liu
CLChenhui Li
Chenhui Li
Feng ShiFeng Shi
Feng Shi
Qing Quan LiuQing Quan Liu
Qing Quan Liu
Jia HuoJia Huo
Jia Huo